An open labeled, randomized, comparative study to evaluate efficacy and safety of fixed dose combination of ceftriaxone + sulbactam (sulbactomax) vs ceftriaxone in patients suffering from various bacterial infections.

Trial Profile

An open labeled, randomized, comparative study to evaluate efficacy and safety of fixed dose combination of ceftriaxone + sulbactam (sulbactomax) vs ceftriaxone in patients suffering from various bacterial infections.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Sep 2016

At a glance

  • Drugs Ceftriaxone/sulbactam (Primary) ; Ceftriaxone
  • Indications Bacterial infections; Bone and joint infections; Meningitis; Otitis media; Postoperative infections; Respiratory tract infections; Septicaemia; Skin infections; Urinary tract infections
  • Focus Therapeutic Use
  • Sponsors Venus Remedies
  • Most Recent Events

    • 06 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top